ASH 2023 Hybrid Group Meetings

Saturday, December 9th to Monday, December 11th, Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into (ASH) American Society of Hematology 2023 updates.

     
    Saturday, December 9th
    12:00 PM ET (9:00 AM PT) - Marc Braunstein // Hybrid
    • Multiple Myeloma | Clinical Assistant Professor of Medicine, NYU Langone Hospitals
    1:00 PM ET (10:00 AM PT) - Muhamed Baljevic // Hybrid
    • Multiple Myeloma, AML/MDS, Leukemia | Disease Team Lead of Plasma Cell Dyscrasias and Lymphomas, Vanderbilt University Medical Center
    2:00 PM ET (11:00 AM PT) - Kevin Kuo // Hybrid
    • Hemoglobinpathies | Associate Professor at Faculty of Medicine, University of Toronto
    2:00 PM ET (11:00 AM PT) - Jae Park // Hybrid
    • Novel CAR-Ts | Attending Physician, Memorial Sloan Kettering Cancer Center
    3:00 PM ET (12:00 PM PT) - Ravi Vij // Hybrid
    • Multiple Myeloma | Professor of Medicine in the Division of Medical Oncology at the Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine
    3:00 PM ET (12:00 PM PT) - Abdulraheem Yacoub // Hybrid
    • Systemic Mastocytosis | Assistant Professor of Medicine, University of Kansas Medical Center
    4:00 PM ET (1:00 PM PT) - Douglas Tremblay // Hybrid
    • MPN (Myelofibrosis, PV, ET) | Physician and Assistant Professor, Mount Sinai Health System Inc.
    4:00 PM ET (1:00 PM PT) - Brad Hunter // Hybrid
    • Sickle Cell | Director of Immune Effector Cell Therapy and attending physician of Bone Marrow Transplant and Medical Oncology, Intermountain Health Care Inc.
    5:00 PM ET (2:00 PM PT) - Ben Samelson-Jones // Hybrid
    • Hemophilia | Assistant Professor of Pediatrics, University of Pennsylvania
    6:00 PM ET (3:00 PM PT) - Joshua Brody // Hybrid
    • Lymphoma | Associate Professor in Hematology and Medical Oncology & Director of the Lymphoma Immunotherapy Program, Mount Sinai Medical Center Inc.
    6:00 PM ET (3:00 PM PT) - Justin Kaner // Hybrid
    • Leukemia, AML/MDS | Assistant Professor, Weill Cornell Medicine
    7:00 PM ET (4:00 PM PT) - David Sallman // Hybrid
    • AML/MDS | Assistant Member, H. Lee Moffitt Cancer Center & Research Institute Inc.
    Sunday, December 10th
    12:00 PM ET (9:00 AM PT) - Ran Reshef // Hybrid
    • Novel CAR-Ts | Director of Translational Research and Blood and Marrow Transplantation Clinical Lead of CAR-T Cell Program and Associate Professor of Medicine, Columbia University Medical Center
    1:00 PM ET (10:00 AM PT) - Richard Drachtman // Hybrid
    • Sickle Cell | Clinical Section Chief of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey
    1:00 PM ET (10:00 AM PT) - Rory Shallis // Hybrid
    • Leukemia, AML/MDS and MPN | Assistant Professor of Medicine (Hematology), Yale University School Of Medicine
    2:00 PM ET (11:00 AM PT) - Preet Chaudhary // Hybrid
    • Novel CAR-Ts | Founder, Angeles Therapeutics
    2:00 PM ET (11:00 AM PT) - Andrew Kuykendall // Hybrid
    • MPN (Myelofibrosis, PV, ET, Systemic Mastocystosis) | Assistant Professor, USF Health
    3:00 PM ET (12:00 PM PT) - Daniel DeAngelo // Hybrid
    • Leukemia, AML/MDS, MPN (Systemic Mastocytosis) | Professor of Medicine, Harvard Medical School
    3:00 PM ET (12:00 PM PT) - Joshua Sasine // Hybrid
    • Novel CAR-Ts | Assistant Professor of Medicine and Founder & Co-Director of the CAR-T Program at Cedars-Sinai Health System
    4:00 PM ET (1:00 PM PT) - Koichi Takahashi // Hybrid
    • Leukemias, AML/MDS | Hematologic Oncologist, University of Texas MD Anderson Cancer Center
    5:00 PM ET (2:00 PM PT) - Izidore Lossos // Hybrid
    • Lymphoma | Professor of Medicine, University of Miami
    5:00 PM ET (2:00 PM PT) - William Matsui // Hybrid
    • Hematologic Malignancy | Deputy Director, Livestrong Foundation Inc.
    6:00 PM ET (3:00 PM PT) - Andrew Branagan // Hybrid
    • Multiple Myeloma | Attending Physician, The General Hospital Corporation
    Monday, December 11th
    12:00 PM ET (9:00 AM PT) - Prithviraj Bose // Hybrid
    • MPN (Myelofibrosis, PV, ET, Systemic Mastocytosis) | Professor, MD Anderson Cancer Center Cooper
    12:00 PM ET (9:00 AM PT) - Nirmish Shah // Hybrid
    • Sickle Cell | Assistant Professor of Medicine and Pediatrics, Duke University
    1:00 PM ET (10:00 AM PT) - Sherif Badawy // Hybrid
    • Non-Malignant Hematology | Associate Professor of the Department of Pediatrics, Northwestern University Feinberg School of Medicine
    1:00 PM ET (10:00 AM PT) - Matthew Matasar // Hybrid
    • Multiple Myeloma, Lymphoma | Division Chief for Blood Disorders and Professor of Medicine, Rutgers Cancer Institute of New Jersey
    2:00 PM ET (11:00 AM PT) - Ashwin Kishtagari // Hybrid
    • MPN (Myelofibrosis, PV, ET), AML/MDS | Assistant Professor of Medicine, Vanderbilt University
    2:00 PM ET (11:00 AM PT) - Julie Kanter-Washko // Hybrid
    • Associate Professor & Director of Sickle Cell Disease Program, University of Alabama at Birmingham
    3:00 PM ET (12:00 PM PT) - Ryan Jacobs // Hybrid
    • CLL, Lymphoma | MD/Principle Investigator, Levine Cancer Institute
    4:00 PM ET (1:00 PM PT) - Uwe Platzbecker // Hybrid
    • Leukemias, AML/MDS | Director Hematology and Cellular Therapy, Universität Leipzig
    4:00 PM ET (1:00 PM PT) - Matthew Frigault // Hybrid
    • Novel CAR-Ts | Assistant Professor, Harvard Medical School
    5:00 PM ET (2:00 PM PT) - Saurabh Dahiya // Hybrid
    • Myeloma & Lymphoma | Associate Professor of Medicine and Clinical Director of Cancer Cell Therapy, Stanford University
    5:00 PM ET (2:00 PM PT) - Sagar Patel // Hybrid
    • Leukemias, Lymphomas, GvHD, Myelofibrosis, MPNs | Assistant Professor, Huntsman Cancer Institute University of Utah Health

    *ASH Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.

    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.